4//SEC Filing
Avnur Zafrira 4
Accession 0001415889-19-000625
CIK 0001035354other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:17 PM ET
Size
12.3 KB
Accession
0001415889-19-000625
Insider Transaction Report
Form 4
Avnur Zafrira
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-05-29+20,000→ 20,000 totalExercise: $9.02Exp: 2029-05-29→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]One half (1/2) of the shares underlying the option shall vest on May 29, 2020 (the "Cliff Vesting Date"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001726049
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 5:17 PM ET
- Size
- 12.3 KB